Introduction
============

*Giardia lamblia* is the causal agent of giardiasis, a prolonged diarrheal disease. The standard compounds used against *Giardia lamblia* are 5-nitroimidazoles. However, these compounds present side effects associated with residual toxicity in the host. Dose-dependent side effects include leukopenia, headache, vertigo, nausea, insomnia, irritability, metallic taste, and CNS toxicity ([@ref-1]; [@ref-25]; [@ref-70]; [@ref-76]). In addition, reports of resistant strains and nitroimidazole-refractory disease are of considerable concern. Reduced efficacy has been described even with higher drug doses ([@ref-15]; [@ref-36]). For these reasons, there is a significant need for identification of new anti-*Giardia* drugs and drug targets. Ionic channels are pore-forming proteins that allow the passage of specific ions across the membrane, regulating different physiological processes ([@ref-69]). Because of their biophysical behavior and participation in different human pathologies, ionic channels are attractive targets for drug design ([@ref-4]). Potassium channels are the most diverse and ubiquitous group of ion channels. They are divided into four main families on the basis of their biophysical and structural properties: voltage-gated K^+^ channels, calcium-activated K^+^ channels (K~Ca~), inward-rectifier K^+^ channels and two-pore-domain K^+^ channels (K~2P~) ([@ref-80]). In both electrically excitable and non-excitable cells, potassium channels regulate multiple cellular functions including cell volume, proliferation, differentiation, and motility ([@ref-28]; [@ref-51]; [@ref-63]; [@ref-74]).

Recently, several studies have reported identification and characterization of K^+^ channels in pathogenic protozoa. In *Plasmodium falciparum* and *Trypanosoma cruzi*, these channels are expressed in different stages of the parasite life cycle. They are essential for growth and play a significant role in parasite response to environmental stresses ([@ref-24]; [@ref-31]; [@ref-75]). A heterodimeric Ca^2+^-activated potassium channel was identified in *Trypanosoma brucei*. This identification was accomplished by profile searches of the predicted parasite proteome against the conserved loop of cation channels. The channel identified was found to be essential for the bloodstream form parasites ([@ref-67]). The National Center for Advancing Translational Sciences Small Molecule Repository was screened. In this screening, fluticasone propionate was identified as a potential good inhibitor of *T. brucei* potassium channels. Experiments confirmed fluticasone propionate as a candidate drug targeting *T. brucei* (IC50 of 0.6 μM) ([@ref-61]). Biaguini and coworkers showed that K^+^ causes an important depolarization of the membrane in *Giardia lamblia* ([@ref-10]). Results of others studies, report that K^+^ plays an important role as an osmolyte regulating *Giardia* cell volume ([@ref-44]). *Xenopus* oocytes were injected with mRNA isolated from trophozoites of *Giardia lamblia*, subsequent electrophysiology experiments revealed potassium currents ([@ref-54]). By genome analysis and a bioinformatic approach, Prole and Marrion identified a putative potassium channel in *Giardia lamblia* assemblage *E* ([@ref-55]). However, the structural characterization of ionic channels in this protozoan is limited. Consequently, the potential of these channels to serve as a drug targets is poorly understood.

In recent years, *in silico* strategies have been used frequently to estimate protein function, for the discovery of new target molecules and for structure-based drug design studies ([@ref-16]). This work describes computational approaches to determine structural biology of a putative *Giardia* potassium channel, GiK. Further, this work evaluates the potential of this channel to serve as a novel target. A closed-state pore domain of GiK homology model was constructed. This construction was accomplished using a high conductance calcium-activated potassium channel from *Aplysia californica* (PDB ID: 5TJI) as a template. Our docking and virtual screening approach identified 110 potassium channel blockers exhibiting high free energy of binding to GiK, 39 of these drugs bind in the pore region of the channel. The drugs interact mainly with sites in three specific regions: S5, S2--S4 and C-terminal. These findings support the conclusion that this protein is an attractive target for biological testing to reveal its role in the life cycle of *Giardia lamblia* and a potential candidate for the design of novel antigiardial drugs.

Materials and Methods
=====================

*In silico* putative potassium channel identification in *Giardia lamblia*
--------------------------------------------------------------------------

To identify homologous sequences in *Giardia lamblia*, 51 potassium channel sequences from genomes of different species, deposited in the NCBI protein database (<http://www.ncbi.nlm.nih.gov/protein>), were compared by BLAST algorithm with the *Giardia* genome database (<http://giardiadb.org/giardiadb/>).

The amino acid composition, physicochemical properties, solvation and protein binding sites of the resulting sequence (GiK) (Accession number [XP_001709490](XP_001709490)) were analyzed using PROTPARAM ((<http://expasy.org/tools/>) and PredictProtein ([@ref-81]). We applied Predictor of Natural Disordered Regions ([@ref-49]) to predict disorder regions. Highly conserved residues were identified by consensus results of NCBI Conserved domains ([@ref-43]), Motif Search (<http://www.genome.jp/tools/motif/>), InterProScan tool ([@ref-32]), Block Searcher ([@ref-29]), and ExPASy PROSITE ([@ref-65]). Consensus results of the Constrained Consensus Topology prediction server ([@ref-72], [@ref-73]) and PredictProtein ([@ref-81]) servers were used for the prediction of transmembrane domains.

Prediction of the potassium blockers binding sites on GiK
---------------------------------------------------------

### Homology model and refinement

The crystal structure of GiK is not available. Therefore, three-dimensional (3D) models of the pore region (1--500 aa) were produced using I-TASSER (Iterative Threading ASSEmbly Refinement) ([@ref-58]; [@ref-82]; [@ref-83]), RaptorX ([@ref-41], [@ref-42]; [@ref-52]), Phyre2 (Protein Homology/analogY Recognition Engine V 2.0) ([@ref-33]), SWISS-MODEL ([@ref-2]; [@ref-11]; [@ref-12]), and Modeller 9.18 ([@ref-27]; [@ref-45]; [@ref-59]; [@ref-77]). First, we searched the PDB ([@ref-6]) for known protein structures using the GiK sequence as query. We also searched for suitable templates in the SWISS-MODEL Template library. Next, a multiple alignment of the GiK sequence (UniProtKB accession: [A8B451](A8B451)) to the main template structures was calculated, by MultAlin software ([@ref-21]). Optimization of the hydrogen bonding network and the atomic level energy minimization of the 3D-GiK models generated were performed using the What If Web Interface ([@ref-18]) and the 3D Refine protein structure refinement server ([@ref-8]; [@ref-9]). The global structural quality of predicted models was validated by RAMPAGE (Ramachandran Plot Analysis) ([@ref-39]), QMEAN (Qualitative Model Energy Analysis) ([@ref-5]), Verify 3D ([@ref-13]; [@ref-40]), ERRAT ([@ref-19]) and ProSA-web ([@ref-78]). The 3D-GiK model with the best scoring was selected for refinement using UCSF CHIMERA v1.11.1 ([@ref-53]). We used 100 steps of conjugate gradient minimization. The QMEANBrane tool was used to assess the local quality of the 3D-GiK membrane protein model ([@ref-68]). To confirm the quality of the models, we compare the 13 resulting 3D models with the corresponding experimental structure using the root mean square deviation (RMSD). TM-align was used to determinate the backbone Cα coordinates of the given protein structures. The results of the predicted models with Cα-RMSD are expressed in Å. The monomer was built by alignment with template 5TJI. Tetrameric assemblage was obtained by the Maestro 2017-1 software with four holo forms monomers of 5TJIs, avoiding overlapping of monomers (Schrödinger, LLC, New York, NY, USA).

Molecular docking evaluation
----------------------------

Numerous structures of potassium blockers have been reported. To identify potential drug binding sites on the GiK protein, we selected 290 potassium blockers from the Drug bank ([www.drugbank.ca](www.drugbank.ca)), Sigma profile ([www.sigmaaldrich.com](www.sigmaaldrich.com)) and Zinc (<http://zinc.docking.org>) ([@ref-30]) databases. Prior to docking, all structures were energy minimized using Maestro 2017-1 (Schrödinger, LLC, New York, NY, USA).

The docking simulations were carried out using AutoDock Vina software, employing a Lamarckian genetic algorithm ([@ref-71]), with a grid box of 126 Å^3^ and nine binding modes. The complexes and poses between 3D-GiK and potassium blockers were analyzed using Maestro 2017-1 (Schrödinger, LLC, New York, NY, USA). The results are reported as binding energy of ligand and protein in kcal/mol.

Results
=======

Identification and characterization of the putative potassium channel GiK
-------------------------------------------------------------------------

We performed BLAST searches of the *Giardia* genome database. We used the whole sequence of 51 potassium channels genomic sequences of different species as queries ([Table S1](#supp-1){ref-type="supplementary-material"}). The uncharacterized protein GL50803_101194, GiK (GenBank Accession: [XP_001709490](XP_001709490)), showed 24--50% identity and 50--90% positivity with 21 different types of voltage-gated potassium channels ([Table 1](#table-1){ref-type="table"}). Physicochemical properties were obtained ([Table 2](#table-2){ref-type="table"}). These properties enabled establishment of GiK molecular weight, stability index, isoelectric point, aliphatic index, and Grand Average of Hydropathicity (GRAVY) of GiK. The instability index indicates that GiK might be unstable in nature (instability index \> 40). The aliphatic index, a factor in protein thermal stability, is related to the mole fraction of Ala, Ile, Leu, and Val in the protein. The aliphatic index of GiK 93.28 indicates a thermally stable protein that contains high amount of hydrophobic amino acids ([Fig. S1](#supp-3){ref-type="supplementary-material"}). The negative value of GRAVY indicates that GiK is a hydrophilic protein ([@ref-79]). The prediction of disordered regions in GiK suggests that this protein has 11 intrinsically disordered regions (IDRs) that could be involved in important *Giardia* functions ([Fig. S2](#supp-4){ref-type="supplementary-material"}). The membrane topology and the analysis of the main features of K^+^ channels show that GiK is a membrane protein that possesses seven helical transmembrane (HTM) regions. Further, evidence shows a highly conserved pore-loop sequence that determines K^+^ channel selectivity ([Fig. 1](#fig-1){ref-type="fig"}). According to databases of protein signatures, GiK contains: a domain related to ionic channels, Ion_trans_2 domain; domains related to voltage-gated potassium channels, 215625 and 236711; one domain associated with signal transduction, 227696; two fingerprints of potassium channel, 2POREKCHANEL and KCHANNEL; and one fingerprint related with EAG/ELK/ERG channels (EAGCHANLFMLY). These results suggest that this protein is a potassium channel ([Fig. 2](#fig-2){ref-type="fig"}; [Table 3](#table-3){ref-type="table"}).
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###### Sequences producing significant alignments with GiK by BLAST.
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  Accession number                       Organism                          Type of channel   Score   *E*. value   Identities     Positives
  -------------------------------------- --------------------------------- ----------------- ------- ------------ -------------- --------------
  **[BAN90095.1](BAN90095.1)**           *Aeropyrum camini*                Kv                32      0.33         15/49 (31%)    29/49 (59%)
  **[AEE68730.1](AEE68730.1)**           *Bordetella pertussis*            Kv                32      0.51         15/43 (35%)    25/43 (58%)
  **[WP_012338231.1](WP_012338231.1)**   *Burkholderia cenocepacia*        Kv                33      0.20         16/39 (41%)    25/39 (64%)
  **[YP_002407586.1](YP_002407586.1)**   *Escherichia coli*                Kv                28.9    8.6          18/66 (27%)    36/66 (55%)
  **[WP_024212520.1](WP_024212520.1)**   *Escherichia spp*                 Multispecies Kv   28.9    9.8          18/66 (27%)    36/66 (55%)
  **[AAP94028.1](AAP94028.1)**           *Gallus gallus*                   Kv1.3             34.7    0.27         20/58 (34%)    32/58 (55%)
  **[WP_011570442.1](WP_011570442.1)**   *Haloquadratum walsby*            Ion channel       33      0.18         10/20 (50%)    18/20 (90%)
  **[AAA61276.1](AAA61276.1)**           *Homo sapiens*                    Kv                35      0.24         16/43 (37%)    25/43 (58%)
  **[NP_002223.3](NP_002223.3)**         *Homo sapiens*                    Kv1.3             35.0    0.17         20/58 (34%)    32/58 (55%)
  **[CDS30290.2](CDS30290.2)**           *Hymenolepis microstoma*          Kv                32.7    2.4          22/80 (28%)    40/80 (50%)
  **[AEO96823.2](AEO96823.2)**           *Lateolabrax japonicus*           Kv1.3             33.1    0.56         18/45 (40%)    26/45 (58%)
  **[CCQ21618.1](CCQ21618.1)**           *Listeria monocytogenes*          Kv                36      0.012        14/41 (34%)    27/41 (66%)
  **[NP_001245037.1](NP_001245037.1)**   *Macaca mulatta*                  Kv1.3             35.0    0.18         20/58 (34%)    32/58 (55%)
  **[NP_032444.2](NP_032444.2)**         *Mus musculus*                    Kv1.3             33.5    0.47         14/38 (37%)    24/38 (63%)
  **[XP_007383667.1](XP_007383667.1)**   *Punctularia strigosozonata*      Kv                44      5e-04        33/105 (31%)   53/105 (50%)
  **[WP_006887331.1](WP_006887331.1)**   *Rothia aeria*                    Kv                36.6    0.032        17/67 (25%)    34/67 (51%)
  **[NP_707157.2](NP_707157.2)**         *Shigella flexneri 2a str. 301*   Kv                29      5.3          18/66 (27%)    36/66 (55%)
  **[CAA56175.1](CAA56175.1)**           *Solanum tuberosum*               Kir               32.0    1.9          18/67 (27%)    34/67 (51%)
  **[NP_631700.1](NP_631700.1)**         *Streptomyces coelicolor*         Kv                30      0.54         9/34 (26%)     24/34 (71%)
  **[CDW52461.1](CDW52461.1)**           *Trichuris trichiura*             Kv                31.6    1.9          12/49 (24%)    27/49 (55%)
  **[AUI87359.1](AUI87359.1)**           *Vibrio azureus*                  Kv                31.6    1.3          27/91 (30%)    46/91 (51%)
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###### Physicochemical characterization of GiK by Protparam.
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  Number of amino acids                         1,416
  --------------------------------------------- ----------
  **Molecular weight**                          25,811.2
  **Instability index**                         45.47
  **Aliphatic index**                           93.28
  **Grand average of hydropathicity (Gravy)**   −0.053
  **Isoelectric point**                         8.18
  **Ext. Coeficiente**                          141,880

![Transmembrane structure of GiK.\
It contains seven transmembrane segments (S1--S7), the P-loops between S5 and S6 form the pore domain. The selectivity filter is in gray.](peerj-07-6430-g001){#fig-1}

![Domains and motifs related to potassium channels.\
GiK presents domains related to different subtypes of potassium channels. (A) Schematic representation. (B) Accession number and description of the sequences.](peerj-07-6430-g002){#fig-2}
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###### Prediction of highly conserved residues from GiK.

![](peerj-07-6430-g011)

  Domain or motif   Description                                                                                       Accession number         Position (*E* value)   Server
  ----------------- ------------------------------------------------------------------------------------------------- ------------------------ ---------------------- ---------------------------------------------------------
  Ion_trans_2       Ionic channel. This family includes the two membrane helix type ion channels found in bacteria.   [pfam07885](pfam07885)   168--245 (1.35e-08)    NCBI Conserved domains, Motif search, InterProScan tool
  227696            EXS domain-containing protein (Signal transduction mechanisms).                                   [COG5409](COG5409)       12--170 (0.44)         ExPASy PROSITE, Motif search
  215625            Voltage-dependent potassium channel; Provisional.                                                 [PLN03192](PLN03192)     181--242 (0.14)        ExPASy PROSITE, Motif search
  236711            Voltage-gated potassium channel; Provisiona.l                                                     [PRK10537](PRK10537)     196--214 (0.70)        ExPASy PROSITE, Motif search
  2POREKCHANEL      Potassium channel domain.                                                                         [PR01333](PR01333)       202--230 (0.00032)     Block searcher
  EAGCHANLFMLY      EAG/ELK/ERG potassium channel family signature.                                                   [PR01463](PR01463)       193--210 (0.029)       Block searcher
  KCHANNEL          Potassium channel signature.                                                                      [PR00169](PR00169)       190--212 (0.1)         Block searcher

The pore-forming domain is highly conserved in all types of K^+^ channels. An alignment revealed that all sequences that showed homology with GiK present the pore signature sequence S/TXGXGX. GiK has the residues SIASIGYGD, similar to TFLSIGYG, which are present in small conductance calcium-activated potassium channels (SKCa) ([@ref-64]) ([Fig. 3](#fig-3){ref-type="fig"}). Finally, using PredictProtein server ([@ref-81]), we predicted GiK has potassium channel activity with 36% reliability.

![Multiple sequence alignment of GiK with voltage-gated potassium channels.\
The signature sequence T/SXGXGX of the selectivity filter is present in all classes of potassium channels (black square).](peerj-07-6430-g003){#fig-3}

Modeling and structure quality of GiK protein
---------------------------------------------

The prediction of the 3D-GiK structure was done by homology modeling. The search for a structural template for GiK protein revealed identity with four resolved protein structures. Two structures were the open and closed state of a high conductance calcium-activated potassium channel from *A. californica* (PDB ID: 5TJ6, open state, and 5TJI, closed state), with 23% sequence identity. The other two structures were the open and closed state of a potassium channel subfamily T member one from *Gallus gallus* (PDB: 5U70, open state, and 5U76, closed state) with 19% sequence identity ([Fig. S3](#supp-5){ref-type="supplementary-material"}).

Model construction was performed using five homology modeling servers: I-TASSER, RaptorX, Phyre2, Swiss model, and Modeller 9.18. Using the four templates, a modeling protocol was constructed for each program. The final dataset includes 13 3D-GiK models covering a wide range of quality. The global quality of each theoretical model was validated by the Ramachandran plot analysis, QMEAN score, Z score, ERRATscore, and Verify 3D. Modeller 9.18 program produced the best 3D-GiK model, using the sequence 5TJI as template ([Table 4](#table-4){ref-type="table"}). [Figures 4A](#fig-4){ref-type="fig"}--[4C](#fig-4){ref-type="fig"} show the resulting ratio of Z-score and the QMEAN score obtained for GiK. The z-score value, −5.07, is in the range of native conformations. This can be seen clearly when the score is compared to the scores of other experimentally determined protein structures with the same number of residues. Further, the QMEAN4 score is in the range of a good experimental structure (0.296). Additionally, the Ramachandran plot analysis confirms that this model is characterized by stereochemical parameters of a stable structure, with 94.2% of residues in the most favored region, 4.6% in the allowed region, and 1.2% in the disallowed region ([Fig. 4](#fig-4){ref-type="fig"}). Finally, according to the QMEANBrane tool estimation, the 3D-GiK model is in the range expected for a membrane protein ([Fig. 5](#fig-5){ref-type="fig"}). [Figure 6](#fig-6){ref-type="fig"} shows the monomeric and tetrameric form, and the pore cavity.
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###### Validation scores from RAMPAGE, QMEAN, ProSA-web, ERRAT, and Verify 3D of the constructed models.

![](peerj-07-6430-g012)

  Software          Template (PDB ID)   Ramachandran (%)   QMEAN score   Z-score   ERRAT score   Verify 3D   Residues   RMSD (Å)
  ----------------- ------------------- ------------------ ------------- --------- ------------- ----------- ---------- ----------
  **Modeller**      5TJ6                90.4               0.141         −7.56     44.26         26.28       500        4.28
                    5U70                90.0               0.094         −8.09     39.62         14.06       500        5.05
                    5TJI                94.2               0.296         −5.07     69.24         35.60       500        3.90
                    5U76                88.4               0.023         −9.22     34.97         26.28       500        4.46
  **Raptorx**       5TJ6                89.8               0.191         −6.92     56.64         20.60       500        4.85
  **I-tasser**      5TJ6                72.9               0.101         −8.78     86.58         38.80       500        3.97
                    5U70                69.6               0.089         −9.12     81.91         44.60       500        5.01
  **Swiss model**   5TJ6                89.8               0.205         −6.21     81.48         33.00       296        0.92
                    5U70                92.8               0.271         −5.53     87.54         39.38       292        0.91
                    5TJI                92.5               0.240         −5.82     88.57         30.98       296        1.12
                    5U76                92.9               0.191         −6.34     84.17         26.35       297        1.17
  **Phyre2**        5TJ6                95.7               0.239         −5.72     61.63         37.36       265        1.01
                    5U76                94.7               0.251         −5.99     35.04         38.44       372        1.10

![Structural validation.\
(A) Normalized QMEAN score of theoretical 3D structure for GiK protein model created with SWISS-MODEL server. (B) Graphical representation of the Z-Score of the individual component of QMEAN. (C) ProSA-web Z-scores of all proteins chains in PDB determined by X-ray crystallography (light blue) or NMR spectroscopy (dark blue). The Z score of GiK is highlighted as a black dot. (D) Ramachandran plot analysis, 94.2% of total residues are in the most favored region.](peerj-07-6430-g004){#fig-4}

![Quality estimation of GiK as a membrane protein.\
Prediction done with SWISS-MODEL-QMEANBrane tool.](peerj-07-6430-g005){#fig-5}

![Representation of the 3D-GiK modeled structure.\
(A) Monomer, (B and C) Tetramer. The images were generated using Maestro software.](peerj-07-6430-g006){#fig-6}

Molecular docking
-----------------

Molecular docking permits prediction of the most probable position, orientation, and conformation of interactions between a ligand and macromolecule ([@ref-26]). To predict binding free energy to GiK, 290 potassium blockers were investigated ([Table S2](#supp-2){ref-type="supplementary-material"}). The overall docking energy of a given ligand molecule was expressed in kcal/mol. This approach revealed 110 molecules exhibiting the best binding free energies (−4 to −11 kcal/mol) ([Table 5](#table-5){ref-type="table"}). Of these, 39 are commercially available compounds. Interestingly, these drugs bind in three specific hydrophobic pockets of GiK. We labeled these regions I, II, and III ([Fig. 7](#fig-7){ref-type="fig"}). As shown in [Table 6](#table-6){ref-type="table"}, 13 residues are important for binding in region I, located on the S6 transmembrane region of the channel. Of these, 10 are hydrophobic and three are polar. For region II, nine residues located on the S5--S6 linker and S6 portion of the channel interact with the various docked ligands. Of these, five are hydrophobic and four are polar. For region III, 12 extracellular residues are important for ligand interaction. Eight are hydrophobic and four are polar. The major residues observed to interact with more of the ligands were Leu65, Gly113, Gln116, Leu117, Tyr120, Met122, Phe125, Ile127, and Arg129, in region II. More negative free binding energy results in the formation of stronger complexes. We analyzed the interaction maps of the three molecules with highest binding free energies that bind to different pockets of the GiK protein. The ligand with the highest score was the K^+^ channel blocker 6,10-diaza-3(1,3)8,(1,4)-dibenzena-1,5(1,4)-diquinolinacy clodecaphane (UCL 1684, −11.2 kcal/mol). This drug was observed to interact with GiK in region I forming hydrophobic interactions with Phe218, Val221, Val222, Leu225, Tyr226, Val247, Leu250, and Leu276. The competitive antagonist of GABA~A~ receptors, bicuculline, had the highest score (−10 kcal/mol) for interaction with GiK in region II. This drug forms: hydrophobic interactions with Gly113, Gln116, Leu117, Tyr118, Tyr120, Met122, Ser124, Phe125, Ser126, and Arg129. Further, bicuculline forms π-π interactions with Phe125 and Tyr68. Finally, the bioactive alkaloid, verruculogen, interacts with GiK site III by hydrophobic interactions with Val348, Pro347, Val377, Met378, and Ile411. Further, verruculogen interacts by polar interaction with Ser346 ([Table 6](#table-6){ref-type="table"}; [Fig. 8](#fig-8){ref-type="fig"}).
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###### Best docking score values (kcal/mol) from the potassium channel blockers to 3D-GiK model.
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  Compound                Docking score (kcal/mol)   Compound            Docking score (kcal/mol)   Compound                      Docking score (kcal/mol)
  ----------------------- -------------------------- ------------------- -------------------------- ----------------------------- --------------------------
  UCL_1684                −11.2                      ZINC13489790        −8                         Flecainide                    −6.9
  ZINC38144725            −10.8                      Imipramine          −7.9                       Mepivacaine                   −6.9
  Terfenadine             −10.6                      Trifluoroperazine   −7.9                       ZINC13489786                  −6.8
  ZINC00018512            −10.4                      ZINC13489791        −7.9                       ZINC13760202                  −6.8
  ZINC00598948            −10.1                      ZINC13489800        −7.9                       ZINC13777065                  −6.8
  Bicuculine              −10                        ZINC13489804        −7.9                       1-Ethyl-2-Benzimidazolinone   −6.7
  Cromoglicic acid        −10                        ZINC13489830        −7.9                       ZINC13760207                  −6.7
  Penitrem_A              −10                        ZINC13760212        −7.9                       ZINC13760214                  −6.7
  BMS_204352              −9.4                       Linopirdine         −7.8                       ZINC03935230                  −6.5
  NS1643                  −9.1                       ZINC13442157        −7.8                       ZINC13557606                  −6.5
  Paxilline               −9.1                       ZINC13489810        −7.8                       ZINC13777062                  −6.5
  CP_339818               −9                         ZINC13489818        −7.8                       ZINC27617403                  −6.5
  Tubocurarine            −8.9                       ZINC13489829        −7.8                       Dofetilide                    −6.4
  ZINC13489797            −8.8                       ZINC13489785        −7.7                       Retigabine                    −6.4
  UK_78282                −8.7                       TRAM_34             −7.6                       ZINC00005768                  −6.4
  Verruculogen            −8.7                       ZINC13489794        −7.6                       ZINC13760203                  −6.4
  ZINC13489806            −8.6                       ZINC13489798        −7.6                       ZINC13777063                  −6.4
  ZINC13644028            −8.6                       ZINC13489784        −7.5                       ZINC13777067                  −6.4
  DIDS                    −8.5                       ZINC13489803        −7.5                       Correolide                    −6.3
  ZINC01535217            −8.5                       ZINC13489813        −7.5                       ZINC03935234                  −6.3
  ZINC13442159            −8.5                       ZINC13557604        −7.5                       ZINC03935235                  −6.3
  ZINC38144724            −8.5                       Amitriptyline       −7.4                       ZINC03946466                  −6.3
  Bicuculine methiodide   −8.4                       Dequalinium         −7.4                       ZINC13777069                  −6.3
  ZINC13489814            −8.4                       ZINC01539875        −7.4                       ZINC13777072                  −6.3
  ZINC13489817            −8.4                       ZINC13489789        −7.4                       Procaine                      −6.2
  ZINC00015850            −8.3                       Quinidine           −7.3                       Zoxazolamine                  −6.1
  ZINC00603820            −8.3                       ZINC00014006        −7.3                       ZINC13777058                  −6
  ZINC01539867            −8.2                       ZINC01535218        −7.3                       ZINC18096411                  −6
  ZINC13489795            −8.2                       ZINC13760206        −7.3                       ZINC13777075                  −5.8
  ZINC13489796            −8.2                       ZINC27617400        −7.3                       ZINC13643922                  −5.7
  ZINC13489807            −8.2                       Psora_4             −7.2                       Chlorzoxazone                 −5.5
  ZINC13489823            −8.2                       ZINC18189761        −7.2                       ZINC13579814                  −5.5
  ZINC29309163            −8.2                       Pimaric_acid        −7.1                       LY_97241                      −5
  Niguldipine             −8.1                       Miconazole          −7                         Clofilium                     −4.8
  ZINC13489799            −8.1                       ZINC13760204        −7                         Halothane                     −4.5
  XE991                   −8                         ZINC13760205        −7                         4_Aminopyridine               −4.4
  ZINC01539870            −8                         ZINC13760213        −7                                                       

![GiK---potassium channel blockers docking simulations (A); (B--D) magnified views of the boxed regions depict the three potassium blockers channels binding sites (blue region I, red region II and green region III).](peerj-07-6430-g007){#fig-7}
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###### Binding sites from the potassium channel blockers to GiK.

![](peerj-07-6430-g014)

  Region    Amino acid residues                                                                                      Potassium channel blockers
  --------- -------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **I**     Phe218, Val221, Val222, Leu225, Tyr226, Leu250, Leu278, Ile279, Ile456, Arg457, Asp488, Val489, Phe490   UCL_1684, terfenadine, cromoglicic acid, CP_339818, niguldipine, imipramine, Psora_4, mepivacaine, procaine, chlorzoxazone, 4_Aminopyridine
  **II**    Leu65, Gly113, Gln116, Leu117, Tyr120, Met122, Phe125, Ile127, Arg129                                    Bicuculine, Penitrem_A, BMS_204352, NS1643, paxilline, tubocurarine, UK_78282, DIDS, bicuculine methiodide, trifluoroperazine, amitriptyline, dequalinium, miconazole, flecainide, 1-Ethyl-2-Benzimidazolinone, correolide,clofilium, halothane
  **III**   Val344, Leu345, Ser346, Val377, Thr379, Gly383, Arg384, Leu388, Leu414, Ala415, Phe418, Pro419           Verruculogen, XE991, linopirdine, TRAM_34, quinidine, pimaric_acid, dofetilide, retigabine, zoxazolamine, LY_97241

![Ligand interaction diagrams.\
UCL 1684 (A), Bicuculline (B) or verruculogen (C). Hydrophobic interactions are depicted by green curves, π--π interactions are in green-dashed lines, and the polar interactions by curve blue lines.](peerj-07-6430-g008){#fig-8}

Discussion
==========

In this report, we provide *in silico* evidence indicating the protein [XP_001709490](XP_001709490) from *Giardia lamblia* (GiK) is a membrane protein, with conserved potassium channels features. GiK presents seven HTM regions and the pore signature sequence SIASIGYGD. This sequence is associated with K^+^ selectivity in SKCa. The presence of the Ion_trans_2 domain related to voltage-gated potassium channels suggests that GiK could be activated by either electrical means or by increasing calcium concentrations in the cell. Additional studies are necessary to understand the voltage-gated and ion selectivity in GiK.

Transmembrane protein GiK presents hydrophobic regions containing a high fraction of non-polar amino acids. It also presents hydrophilic regions containing a high fraction of polar amino acids ([Figs. S1](#supp-3){ref-type="supplementary-material"} and [S4](#supp-6){ref-type="supplementary-material"}). The GRAVY value of −0.053 indicates that GiK could establish interactions with water; it can be highly hydrated in aqueous media. GiK contains protein regions that do not fold into defined tertiary structure. These are structural disorders commonly labeled IDRs. IDRs perform a central role in regulation of signaling pathways and crucial cellular processes. They are frequently associated with disease. For these reasons, there is growing interest in IDRs as potential targets for drug design ([@ref-14]; [@ref-17]). The prediction of 14 flexible disordered regions in GiK suggests that this protein may be important in various *Giardia* functions. This important preliminary evidence indicates that GiK is a promising subject for future study.

Potassium channels regulate multiple cellular functions in both electrically excitable and non-excitable cells. Therefore, they are attractive targets for drug design. Current trends in drug discovery focus on target identification and *in silico* compound design. We sought to determine whether GiK could be a potential drug target in *Giardia*. First, we built structural models of the transmembrane helical regions of GiK by homology modeling. The search for templates showed only two resolved structures: a high conductance calcium-activated potassium channel from *A. californica* (PDB ID: 5TJ6 and 5TJI) and a potassium channel subfamily T member one from *Gallus gallus* (PDB: 5U70 and 5U76). In this work, GiK presents 23% and 19% of sequence identity with the templates. RMSD is a quantitative measure of the similarity between two superimposed atomic coordinates. When using RMSD to compare protein structures, the RMSD distribution depends on the size of the protein and of the homology between the templates, among others ([@ref-35]). Using multiple approaches we generated 13 structural models of GiK, the quality analysis of individual models showed that even though, models obtained with Swiss model and Phyre2 had the lower RMSD values, only 50--70% of residues were modeled. The percentage of residues in the allowed regions was expected to be more than 90% for a good model. The Modeller program produced acceptable models. The best result was obtained employing the PDB ID: 5TJI (closed state); 500 aa aligned, results from a Ramachandran plot showed 94.2% of residues in the most favored region. Even though the structures obtained with 5U70 and 5TJ6 showed 90% of residues in the most favored region, the overall quality factor ([@ref-4]) value of 5TJI is the highest (69.24%) and is within the accepted range. Besides, it is important to emphasize that in addition to RMSD, the generation of Z-score is also a measure of statistical significance between matched structures and reflects the degree of modeling success ([@ref-22]), the *Z*-score value (−5.07) indicates that the overall geometrical quality of the model generated by Modeller using the template 5TJI was within the acceptable range for big proteins. The overall results from RAMPAGE, QMEAN and Verify 3D indicate the 3D modeled GiK protein is of good quality. After building the 3D structure of GiK, we screened 290 potassium channel blockers. The docking results showed 110 potassium channel blockers with high affinity for the GiK protein. A total of 39 of these showed similar binding modes in three specific regions, labelled I to III. They interact principally with hydrophobic and aromatic residues such as Phe, Tyr, Leu, and Val. In agreement with results described for different potassium blockers, the ring stacking, hydrophobic interactions with several aromatic side chains and polar interactions take place mainly in S5 and S6 ([@ref-47]; [@ref-60]). The ionic channels can be switched or gated between an open and closed state by external signals such as changes in transmembrane voltage, binding of ligands, and mechanical stress. Some K^+^ channels possess a highly hydrophobic inner pore that can function as an effective barrier to ion permeation ([@ref-3]). Our results suggest that GiK is a calcium potassium activated channel with a hydrophobic inner pore. Additional research is needed to confirm this finding. We plan to expand our studies in this area in the future ([@ref-37]; [@ref-46]).

Other authors have reported successful computational screening of K^+^ channels. These reports demonstrate that computational screening is an effective method for rapidly discovering new channels blockers from large databases ([@ref-34]; [@ref-38]). Hong Liu and coworkers identified 14 natural compound of relatively lower binding energy. These researchers used a docking virtual screening approach based upon a 3D model of the eukaryotic K^+^ channels. Experimental results showed that four of these exerted potent and selective inhibitory effect on K^+^ channels ([@ref-38]). Interestingly, some of the potassium channel blockers in our study have been employed with some success for their antiparasite activity. Verruculogen, clofilium, clotrimazole, trifluoroperazine, bicuculline methiodide, tubocurarin, and dequalinium chloride affect the growth of *Trypanosoma bruceii*, *Leishmania donovani, Plasmodium falciparum, and Trichomonas vaginalis* ([@ref-23]; [@ref-48]; [@ref-56]; [@ref-75]). Quinidine inhibits the cell division in *Tetrahymena pyriformis* ([@ref-20]). Trifluoperazine alters the motility in *Paramecium sp*. ([@ref-50]). Disodium cromoglycate and terfenadine show activity in infection models of *Toxoplasma gondii* and *Plasmodium yoelli nigeriensis* ([@ref-57]; [@ref-66]). In *Giardia lamblia*, trifluoroperazine, a calmodulin antagonist, inhibits excystment ([@ref-7]). It remains uncertain whether potassium channels are the targets of these compounds.

Conclusion
==========

Using structural bioinformatics, we identified the hypothetical protein [XP_001709490](XP_001709490) from *Giardia lamblia* as a potassium channel, GiK. By protein docking analysis, we found 39 commercial potassium channel blockers that have affinity for this protein. These blockers are predicted to bind in three specific regions on the protein. The novelty of this work lies in the use of the model 3D-GiK structure to screen compounds with theoretical affinity. Some of the drugs predicted by the model to be effective have demonstrated antiparasitic activity in *in vitro* and *in vivo* assays. Experimental analyses are needed to confirm the activity of these drugs on *Giardia*. The low homology of GiK with proteins in the human genome contributes to its potential as a target of specific pharmacological agents.
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###### GenBank accession numbers for sequences used in the GiK identification.

A total of 51 potassium channel sequences from genomes of different species, deposited in the NCBI protein database (<http://www.ncbi.nlm.nih.gov/protein>), were compared by BLAST algorithm with the *Giardia* genome database (<http://giardiadb.org/giardiadb/>).

###### 

Click here for additional data file.
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###### Potassium channel blockers used in the docking assays.

A total of 290 compounds were docked.

###### 

Click here for additional data file.
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###### Amino acid composition of GiK.

###### 

Click here for additional data file.
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###### Graphical representation of hypothetical disordered regions of GiK.

Values above 0.5 indicate disorder, below 0.5 indicate order.

###### 

Click here for additional data file.
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###### Sequence alignment with MultiAlin showing the high consensus (red) and low consensus (blue) regions, between the sequence of GiK and the template proteins (Q5QJC5_Aplysia, Q8QFV0_Gallus, Uniprot file).

###### 

Click here for additional data file.
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###### Kyte-Doolittle-Hydropathy Plot for GiK.

The hydrophobic residues are shown above zero, whereas the hydrophilic residues are below zero. .

###### 

Click here for additional data file.
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